
Keywords: Broad-spectrum antivirals; Non-nucleoside inhibitors; Direct-acting antivirals; Norovirus; RNA-dependent RNA polymerase; Caliciviridae; BS-AV; broad-spectrum antivirals; CI; confidence intervals; FCV; feline calicivirus; IC50; half maximal inhibitory conc